Last reviewed · How we verify

NCT05282225

Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care

Active, enrolled NA Last updated 24 November 2025
What this trial tests

NA trial testing MI- Safety Plan in Suicide in 300 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
7 November 2022
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposetreatment
Enrollment300
Start date7 November 2022
Primary completion30 June 2026
Estimated completion30 June 2026
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

Adults 13 to 17, any sex, with Suicide or Suicide, Attempted. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being completed to examine different combinations of technology-augmented strategies to identify an effective Adaptive intervention (AI) addressing post-discharge suicide risk with high implementation potential.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05282225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing